Literature DB >> 9422946

Gene therapy for tissue repair: approaches and prospects.

S A Eming1, J R Morgan, A Berger.   

Abstract

Recent advances in molecular biology have resulted in the development of new technologies for the introduction and expression of genes in human somatic cells. This emerging field, known as gene therapy, is broadly defined as the transfer of genetic material to cells/tissues in order to achieve a therapeutic effect for inherited as well as acquired diseases. We and others are exploring the potential application of this technology to tissue repair. One primary focus has been to transfer genes encoding wound healing growth factors, a broad class of proteins which control local events in tissues such as cell proliferation, cell migration and the formation of extracellular matrix. Using several different strategies for gene transfer, wound healing growth factor genes have been introduced and expressed in cells and tissues in vitro as well as in vivo. Various experimental models of wound healing and tissue repair have been used to evaluate the efficacy of this new and exciting approach to tissue repair.

Entities:  

Mesh:

Year:  1997        PMID: 9422946     DOI: 10.1016/s0007-1226(97)91297-2

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  3 in total

Review 1.  Wound healing enhancement: electroporation to address a classic problem of military medicine.

Authors:  Mark Ferguson; Colman Byrnes; Leon Sun; Guy Marti; Pramod Bonde; Mark Duncan; John W Harmon
Journal:  World J Surg       Date:  2005       Impact factor: 3.352

Review 2.  Gene therapy and wound healing.

Authors:  Sabine A Eming; Thomas Krieg; Jeffrey M Davidson
Journal:  Clin Dermatol       Date:  2007 Jan-Feb       Impact factor: 3.541

3.  Adenoviral gene delivery to primary human cutaneous cells and burn wounds.

Authors:  Tobias Hirsch; Sebastian von Peter; Grzegorz Dubin; Dominik Mittler; Frank Jacobsen; Markus Lehnhardt; Elof Eriksson; Hans-Ulrich Steinau; Lars Steinstraesser
Journal:  Mol Med       Date:  2006 Sep-Oct       Impact factor: 6.354

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.